Veracyte VP withholds 3,006 shares for taxes

VERACYTE, INC. executive Jonathan Wygant, the VP and Chief Accounting Officer, reported a tax-related share disposition.

Rhea-AI Filing Summary

VERACYTE, INC. executive Jonathan Wygant, the VP and Chief Accounting Officer, reported a tax-related share disposition. On March 2, 2026, 3,006 shares of common stock were withheld at $36.01 per share to cover tax obligations from vesting restricted stock units, and the footnote states this does not represent a sale. Following this withholding, he directly holds 34,909 shares of Veracyte common stock, including 495 shares purchased on January 31, 2026 through the company’s Employee Stock Purchase Plan.

Insider Trade Summary

Exercise Price or Tax Liability: 3,006 shares

Exercise Price or Tax Liability 1 txn

Insider Wygant Jonathan

Role VP, Chief Accounting Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	3,006	$36.01	$108K

Holdings After Transaction: Common Stock — 34,909 shares (Direct)

Footnotes (2)

1. F1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on March 2, 2026 and does not represent a sale.
2. F2. Includes 495 shares of common stock purchased on January 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Veracyte (VCYT) executive Jonathan Wygant report?

Jonathan Wygant reported a tax-related disposition of Veracyte shares. On March 2, 2026, 3,006 common shares were withheld to satisfy his tax obligations from vesting restricted stock units, rather than being sold in the open market.

Was the Veracyte (VCYT) Form 4 transaction a sale of shares?

The Form 4 transaction was not a sale of shares. Footnotes explain that 3,006 Veracyte common shares were withheld on March 2, 2026 solely to satisfy Jonathan Wygant’s tax withholding obligations linked to vesting restricted stock units.

How many Veracyte (VCYT) shares does Jonathan Wygant own after the Form 4 event?

After the March 2, 2026 tax-withholding disposition, Jonathan Wygant directly owns 34,909 Veracyte common shares. This total includes 495 shares purchased on January 31, 2026 through the Veracyte, Inc. Employee Stock Purchase Plan.

What was the price per share used in the Veracyte (VCYT) tax-withholding transaction?

The shares withheld for taxes were valued at $36.01 per Veracyte common share. This price was applied to the 3,006 shares withheld on March 2, 2026 to cover Jonathan Wygant’s tax obligations from his vesting restricted stock units.

What triggered the Veracyte (VCYT) insider tax-withholding disposition on March 2, 2026?

The disposition was triggered by vesting restricted stock units. When these units vested on March 2, 2026, 3,006 Veracyte common shares were automatically withheld to satisfy Jonathan Wygant’s tax withholding obligations, as disclosed in the Form 4 footnote.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 04:17 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wygant Jonathan

(Last) (First) (Middle)

6000 SHORELINE COURT, SUITE 300

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		F(1)		3,006	D	$36.01	34,909(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on March 2, 2026 and does not represent a sale.

2. Includes 495 shares of common stock purchased on January 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.

Remarks:

	/s/ Jonathan Wygant	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.